Mechanical Circulatory Support Options in Patients With Aortic Valve Pathology.


Journal

Journal of cardiothoracic and vascular anesthesia
ISSN: 1532-8422
Titre abrégé: J Cardiothorac Vasc Anesth
Pays: United States
ID NLM: 9110208

Informations de publication

Date de publication:
08 2022
Historique:
received: 27 01 2022
revised: 29 03 2022
accepted: 07 04 2022
pubmed: 12 5 2022
medline: 16 6 2022
entrez: 11 5 2022
Statut: ppublish

Résumé

Mechanical circulatory support (MCS) is used in cardiogenic shock for periprocedural hemodynamic stability in high-risk patients and to support patients with symptomatic coronary artery disease. Depending on the MCS type, oxygenation and ventilation, in addition to increasing blood pressure by augmenting blood flow, can be achieved. MCS typically follows a failure of less invasive maneuvers or intolerance to them, such as significant ventricular arrhythmia burden from inotropic support. MCS options include intra-aortic balloon pump, transvalvular percutaneous left ventricular assist devices, venoarterial extracorporeal membrane oxygenation, and surgically implanted left ventricular assist devices. The number of MCS options has increased, and this has made the decision-making process complicated. MCS decision-making is complex, even in patients without valvular pathology. The presence of aortic valve (AV) abnormalities, such as aortic stenosis, aortic insufficiency, replaced AVs, or AV masses, adds even further to the challenge of selecting the appropriate support strategy. In this narrative review, a concise review of MCS options and the special considerations for various AV pathologies are presented.

Identifiants

pubmed: 35545462
pii: S1053-0770(22)00269-5
doi: 10.1053/j.jvca.2022.04.010
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

3318-3326

Informations de copyright

Copyright © 2022 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Conflicts of Interest None.

Auteurs

Jeans Miguel Santana (JM)

Department of Anesthesiology and Perioperative Medicine, Tufts Medical Center, Boston, MA.

Adam A Dalia (AA)

Division of Cardiac Anesthesiology, Massachusetts General Hospital, Harvard Medical School, Boston, MA.

Melinda Newton (M)

Department of Respiratory Care, Tufts Medical Center, Boston, MA.

Dominic V Pisano (DV)

Department of Anesthesiology and Perioperative Medicine, Tufts Medical Center, Boston, MA.

Sarah Eapen (S)

CardioVascular Center, Cardiac Surgery, Tufts Medical Center, Boston, MA.

Masashi Kawabori (M)

CardioVascular Center, Cardiac Surgery, Tufts Medical Center, Boston, MA.

Jamel Ortoleva (J)

Department of Anesthesiology and Perioperative Medicine, TuftsMedical Center, 800 Washington Street, Ziskind Building 6th Floor, Boston, MA02111. Electronic address: jortoleva@tuftsmedicalcenter.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH